Advancing prognostic precision in gastric cancer with an immunoinflammatory index.
Gastric cancer remains a major global health challenge with high morbidity and mortality rates.
APA
Zhang HM, Wang GH, et al. (2024). Advancing prognostic precision in gastric cancer with an immunoinflammatory index.. World journal of gastroenterology, 30(44), 4754-4758. https://doi.org/10.3748/wjg.v30.i44.4754
MLA
Zhang HM, et al.. "Advancing prognostic precision in gastric cancer with an immunoinflammatory index.." World journal of gastroenterology, vol. 30, no. 44, 2024, pp. 4754-4758.
PMID
39610779
Abstract
Gastric cancer remains a major global health challenge with high morbidity and mortality rates. Recent advancements in immunology and inflammation research have highlighted the crucial roles that these biological processes play in tumor progression and patient outcomes. This has sparked new interest in developing prognostic biomarkers that integrate these two key biological processes. In this letter, we discuss the recent study by Ba , which proposed a novel prognostic immunoinflammatory index for patients with gastric cancer. We underscore the importance of this research, its potential impact on medical practice, and the prospective avenues for further investigation in this rapidly emerging area of study.
MeSH Terms
Stomach Neoplasms; Humans; Prognosis; Biomarkers, Tumor; Inflammation; Disease Progression
같은 제1저자의 인용 많은 논문 (5)
- Anatomical structure of the buccal fat pad and its clinical adaptations.
- High PD-L1 expression as a negative prognostic factor in stage III but not in stage II gastric cancer.
- [Mechanism of vitamin K2 in modulating matrix Gla protein to inhibit tumor growth in inflammation-associated colorectal cancer model mice].
- GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A.
- Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer.